South African women living with HIV subtype C experience rapid CD4 cell loss
Mothers starting antiretrovirals in Malawi lost from care more frequently, revealing weaknesses in Option B+ implementation
Switching from first-line ART with suppressed viral load linked to treatment failure
Of guidelines, targets and resources: the documents that defined the 2014 International AIDS Conference
Efavirenz use not linked to neurocognitive impairment
Strong performance on HIV drugs for mothers doesn't guarantee optimal care for infants, survey shows
Dolutegravir demonstrates good efficacy despite resistance
Could HIV treatment mean safer sex?
Maraviroc fails to match tenofovir/emtricitabine for first-line HIV treatment
